December 3, 2024 10:25 AM EST
News Briefing

BMS inks deal with AI Pro­teins; Terns’ ear­ly-stage leukemia da­ta

ENDPOINTS

Plus, news about IPOs in Hong Kong, In­ven­tis­Bio and Al­li­ga­tor Bio­science:

Bris­tol My­ers Squibb part­ners with AI Pro­teins: The deal will

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

Co­herus makes fi­nal, $483M piv­ot away from biosim­i­lars

GSK ter­mi­nates Phase 2 tri­al of HBV ther­a­peu­tic vac­cine

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

A service from the Financial Times